alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2016475EN.01001602.xml

| 19.12.2016 | EN | Official Journal of the European Union | C 475/16 |
| --- | --- | --- | --- |

19.12.2016

EN

Official Journal of the European Union

C 475/16

---

Order of the General Court of 15 September 2016 — Kurchenko v Council

(Case T-339/14) (1)

1

((Common foreign and security policy - Restrictive measures taken in view of the situation in Ukraine - Freezing of funds - Applicant not represented by a lawyer - Applicant having ceased to reply to the Court’s requests - No need to adjudicate))

(2016/C 475/26)

Language of the case: English

Parties

Parties

Applicant: Serhiy Vitaliyovych Kurchenko (Chuhuiv, Ukraine) (represented by: B. Kennelly, QC, J. Pobjoy, Barrister, M. Drury, A. Swan, and J. Binns, Solicitors)

Applicant:

Defendant: Council of the European Union (represented by: Á. de Elera-San Miguel Hurtado and J.-P. Hix, Agents)

Defendant:

Intervener in support of the defendant: European Commission (represented by: S. Bartelt and D. Gauci, Agents)

Intervener in support of the defendant

Re:

Re:

Application under Article 263 TFEU for annulment, first, of Council Decision 2014/119/CFSP of 5 March 2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine (OJ 2014 L 66, p. 26) and Council Regulation (EU) No 208/2014 of 5 March 2014 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Ukraine (OJ 2014 L 66, p. 1), and, secondly, Council Decision (CFSP) 2015/364 of 5 March 2015 amending Decision 2014/119 (OJ 2015 L 62, p. 25) and Council Implementing Regulation (EU) 2015/357 of 5 March 2015 implementing Regulation No 208/2014 (OJ 2015 L 62, p. 1), in so far as those measures apply to the applicant, and, in the alternative, an application under Article 277 TFEU for a declaration of the inapplicability to the applicant of Article 1(1) of Decision 2014/119, as amended by Council Decision (CFSP) 2015/143 of 29 January 2015 amending Decision 2014/119 (OJ 2015 L 24, p. 16) and of Article 3(1) of Regulation No 208/2014, as amended by Council Regulation (EU) 2015/138 of 29 January 2015 amending Regulation No 208/2014 (OJ 2015 L 24, p. 1).

Operative part of the order

Operative part of the order

| 1. | There is no need to adjudicate on this action. |
| --- | --- |

1.

There is no need to adjudicate on this action.

| 2. | Mr Serhiy Vitaliyovych Kurchenko shall bear his own costs and pay those of the Council of the European Union. |
| --- | --- |

2.

Mr Serhiy Vitaliyovych Kurchenko shall bear his own costs and pay those of the Council of the European Union.

| 3. | The European Commission shall bear its own costs. |
| --- | --- |

3.

The European Commission shall bear its own costs.

---

(1)  OJ C 253, 4.8.2014.

1

---
§ 876.4680 Ureteral stone dislodger. ( a ) *Identification.* A ureteral stone dislodger is a device that consists of a bougie or a catheter with an expandable wire basket near the tip, a special flexible tip, or other special construction. It is inserted through a cystoscope and used to entrap and remove stones from the ureter. This generic type of device includes the metal basket and the flexible ureteral stone dislodger.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.
[48 FR 53023, Nov. 23, 1983, as amended at 63 FR 59228, Nov. 3, 1998]
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1630 Protein (fractionation) test system. ( a ) *Identification.* A protein (fractionation) test system is a device intended to measure protein fractions in blood, urine, cerebrospinal fluid, and other body fluids. Protein fractionations are used as an aid in recognizing abnormal proteins in body fluids and genetic variants of proteins produced in diseases with tissue destruction.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2308, Jan. 14, 2000]
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-4611]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ID-3716-001]


Ellsworth, David C.; Notice of Filing

February 25, 2010.
    Take notice that on February 12, 2010, David C. Ellsworth filed an 
informational report for authority to hold interlocking positions, 
pursuant to section 45.9 of the Commission's Regulations, 18 CFR 45.9 
(2009).
    Any person desiring to intervene or to protest this filing must 
file in accordance with Rules 211 and 214 of the Commission's Rules of 
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be 
considered by the Commission in determining the appropriate action to 
be taken, but will not serve to make protestants parties to the 
proceeding. Any person wishing to become a party must file a notice of 
intervention or motion to intervene, as appropriate. Such notices, 
motions, or protests must be filed on or before the comment date. 
Anyone filing a motion to intervene or protest must serve a copy of 
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an 
original and 14 copies of the protest or intervention to the Federal 
Energy Regulatory Commission, 888 First Street, NE., Washington, DC 
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the 
``eLibrary'' link and is available for review in the Commission's 
Public Reference Room in Washington, DC. There is an ``eSubscription'' 
link on the Web site that enables subscribers to receive e-mail 
notification when a document is added to a subscribed docket(s). For 
assistance with any FERC Online service, please e-mail 
<a href="/cdn-cgi/l/email-protection#7a3c3f283935141613141f290f0a0a15080e3a1c1f0819541d150c"><span class="__cf_email__" data-cfemail="65232037262a0b090c0b00361015150a171125030017064b020a13">[email protected]</span></a>, or call (866) 208-3676 (toll free). For 
TTY, call (202) 502-8659.
    Comment Date: 5 p.m. Eastern Time on March 5, 2010.

Kimberly D. Bose,
Secretary.
[FR Doc. 2010-4611 Filed 3-4-10; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1165 n-Butane and iso-butane. ( a ) n-Butane and iso-butane (empirical formula C4H10, CAS Reg. Nos. 106-97-8 and 75-28-5, respectively) are colorless, flammable gases at normal temperatures and pressures. They are easily liquefied under pressure at room temperature and are stored and shipped in the liquid state. The butanes are obtained from natural gas by fractionation following absorption in oil, adsorption to surface-active agents, or refrigeration.
( b ) The ingredients must be of a purity suitable for their intended use.
( c ) In accordance with § 184.1(b)(1), these ingredients are used in food with no limitations other than current good manufacturing practice. The affirmation of these ingredients as generally recognized as safe (GRAS) as direct human food ingredients is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredients are used as propellants, aerating agents, and gases as defined in § 170.3(o)(25) of this chapter.
( 2 ) The ingredients are used in food at levels not to exceed current good manufacturing practice.
( d ) Prior sanctions for these ingredients different from the uses established in this section do not exist or have been waived.
[48 FR 57270, Dec. 29, 1983, as amended at 73 FR 8607, Feb. 14, 2008; 76 FR 59249, Sept. 26, 2011]
#### Katzow v. Borinstein

[No. 17,386.

Filed October 22, 1945.

Rehearing Denied November 16, 1945. Transfer Denied December 21, 1945.]

*Alvah J. Rucker,*of Indianapolis, and *George R. Tolen,*of Shelbyville, for appellant.

*Joseph & Dann,*of Indianapolis, and *Pell & Pell,*of Shelbyville, for appellee.

*700Flanagan, J.

This is the. second appeal of this case. See *Borinstein*v. *Katzow*(1944), 222 Ind. 548, 55 N. E. (2d) 260. On the former appeal the Supreme Court decided that the complaint was demurrable. .

An amended complaint was then filed in the trial court and a demurrer sustained to it. This appeal is from that ruling.

There is no substantial difference between the amended and the original ’complaint. The operative facts remain the same. Our Supreme Court held that such operative facts do not constitute a cause of action.

Judgment affirmed.

Note. — Reported in 63 N. E. (2d) 146.
FORM 10-Q

Securities and Exchange Commission

Washington, D.C.  20549

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  **June 30, 2001**
[   ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 

SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________.

Commission File No. 0-22372.
**GRAND TOYS INTERNATIONAL, INC.**
(Exact Name of Registrant as Specified in its Charter)	

		

Nevada	      	                  					98-0163743 	      	      	     
(State or other jurisdiction of					(I.R.S. Employer

incorporation or organization					Identification No.)

1710 Route Transcanadienne, Dorval, Quebec, Canada, H9P 1H7

(Address of principal executive offices)

(514) 685-2180

(Registrants telephone number, including Area Code)

 

(Former name, former address and former fiscal year, 

if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes	    X   		No    _____

Indicate the number of shares outstanding of each of the Issuers classes of common equity, as of August 14, 2001: 5,088,477.

 
**GRAND TOYS INTERNATIONAL, INC.

 

Index to Quarterly Report on Form 10 Q

Filed with the Securities and Exchange Commission
**Period ended June 30, 2001****ITEMS IN FORM 10 Q **Page**Part I - Financial Information   
Item 1.  Consolidated Financial Statements:   
Consolidated Balance Sheets 

      at June 30, 2001 and December 31, 2000
3-4
Consolidated Statements of Operations

      For the Three Month and Six Month Periods

      Ended June 30, 2001 and 2000
5
Consolidated Statements of Stockholders Equity and Comprehensive

      Income 
6
Consolidated Statements of Cash Flows

      For the Six Month Period

      Ended June 30, 2001 and 2000
7
Notes to Consolidated Financial Statements
8-18  
Item 2.  Managements Discussion and Analysis of Financial Condition

             and Results of Operations
19-23
Item 3. Quantitative and Qualitative Disclosures About Market Risks
24
  **Part II - Other Information   
Item 1.  Legal proceedings
24
Item 2.  Changes in Securities and Use of Proceeds
24
Item 3.  Defaults Upon Senior Securities
25
Item 4.  Submission of Matters to a Vote of Security Holders
25
Item 5.  Other Information
25
Item 6.  Exhibits and Reports on Form 8-K
25  
Signatures
26-27** 

 

Part I. - Financial Information
***Item 1.  Financial Statements*
Consolidated Balance Sheets
 
June 30, 2001
December 31, 2000 
(Unaudited) **Assets     
Current assets:
Cash (note 2)
$        203,370
$        211,515
Accounts receivable (net of allowance for doubtful	****************
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.5600 Automated hematocrit instrument. ( a ) *Identification.* An automated hematocrit instrument is a fully automated or semi-automated device which may or may not be part of a larger system. This device measures the packed red cell volume of a blood sample to distinguish normal from abnormal states, such as anemia and erythrocytosis (an increase in the number of red cells).
( b ) *Classification.* Class II (performance standards).
[45 FR 60600, Sept. 12, 1980]
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.2860 Mass spectrometer for clinical use. ( a ) *Identification.* A mass spectrometer for clinical use is a device intended to identify inorganic or organic compounds (e.g., lead, mercury, and drugs) in human specimens by ionizing the compound under investigation and separating the resulting ions by means of an electrical and magnetic field according to their mass.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2309, Jan. 14, 2000]
§ 876.4530 Gastroenterology-urology fiberoptic retractor. ( a ) *Identification.* A gastroenterology-urology fiberoptic retractor is a device that consists of a mechanical retractor with a fiberoptic light system that is used to illuminate deep surgical sites.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
[48 FR 53023, Nov. 23, 1983, as amended at 54 FR 25049, June 12, 1989; 66 FR 38801, July 25, 2001]
<PAGE>   1
                                                                    EXHIBIT 23.3


CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
Logical Software Solutions Corporation:

We consent to the incorporation by reference herein of our report dated June 
30, 1998, with respect to the balance sheet of Logical Software Solutions 
Corporation as of December 31, 1997, and the related statements of operations, 
stockholders' equity, and cash flows for the year then ended, which report 
appears in the June 30, 1998, current report on Form 8-K/A of INTERLINQ 
Software Corporation and to the reference to our firm under the heading 
"Experts" in the Proxy Statement/Prospectus.

/S/KPMG LLP

Seattle, Washington
April 23, 1999
#### UNITED STATES of America, Appellee, v. Monroe Britton HILL, Appellant.

No. 86-5050.

United States Court of Appeals, Eighth Circuit.

Submitted May 6, 1986.

Decided July 2, 1986.

Barry Voss, Minneapolis, Minn., for appellant.

Paul A. Murphy, Asst. U.S. Atty., Minneapolis, Minn., for appellee.

Before HEANEY, JOHN R. GIBSON, and FAGG, Circuit Judges.

PER CURIAM.

Monroe Britton Hill was convicted of aiding and abetting a bank robbery in violation of 18 U.S.C. § 2113(a), (d) and 18 U.S.C. § 2. He was sentenced to three years. He contends on appeal that the evidence was insufficient to sustain the conviction.

After a careful review of the briefs and records, we affirm. There was more than sufficient evidence from which the jury could find that Hill used his car to pick up the robbers immediately after the crime occurred at the scene of the crime, and that he did so knowing that the men he had picked up had just committed a robbery. There is, moreover, creditable evidence from which the jury could find that Hill shared in the proceeds of the robbery. This evidence is sufficient to prove aiding and abetting a robbery. *United States v. Cady,*495 F.2d 742 (8th Cir.1974); *United States v. Johnson,*462 F.2d 608 (8th Cir. 1972).

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND THE STATEMENTS OF REVENUE AND EXPENSES AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH REPORT ON FORM 10-Q
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                       2,020,129
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               2,893,095
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   2,878,598
<TOTAL-LIABILITY-AND-EQUITY>                 2,893,095
<SALES>                                              0
<TOTAL-REVENUES>                                23,049
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                34,545
<LOSS-PROVISION>                               (5,301)
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (309,388)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
EX-31 Rule13a-14(d)/15d-14(d) Certifications.

 

 

I, Anthony Sfarra,certify that:

 

1. I have reviewedthis report on Form 10-K and all reports on Form 10-D required to be filed in respectof the period covered by this report on Form 10-K of the Wells Fargo CommercialMortgage Trust 2015-C30 (the "Exchange Act periodic reports");

 

2. Based on myknowledge, the Exchange Act periodic reports, taken as a whole, do not containany untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3. Based on my knowledge,all of the distribution, servicing and other information required to beprovided under Form 10-D for the period covered by this report is included inthe Exchange Act periodic reports;

 

4. Based on myknowledge and the servicer compliance statements required in this report underItem 1123 of Regulation AB, and except as disclosed in the Exchange Actperiodic reports, the servicers have fulfilled their obligations under theservicing agreements in all material respects; and

 

5. All of the reportson assessment of compliance with servicing criteria for asset-backed securitiesand their related attestation reports on assessment of compliance withservicing criteria for asset-backed securities required to be included in thisreport in accordance with Item 1122 of Regulation AB and Exchange Act Rules13a-18 and 15d-18 have been included as an exhibit to this report, except asotherwise disclosed in this report. Any material instances of noncompliancedescribed in such reports have been disclosed in this report on Form 10-K.

 

In giving thecertifications above, I have reasonably relied on information provided to me bythe following unaffiliated parties:

 

National CooperativeBank, N.A., as NCB Master Servicer, CWCapital Asset Management LLC, as SpecialServicer prior to July 5, 2018, Rialto Capital Advisors, LLC, as SpecialServicer on and after July 5, 2018, National Cooperative Bank, N.A., as NCBSpecial Servicer, Wilmington Trust, National Association, as Trustee, PentalphaSurveillance LLC, as Trust Advisor, CoreLogic Commercial Real Estate Services,Inc., as Servicing Function Participant, and National Tax Search, LLC, asServicing Function Participant.

 

 

 

Dated: March 19, 2019

 

 

/s/ Anthony Sfarra

 

 

President

(seniorofficer in charge of securitization of the depositor)
**Exhibit 32.2**

 

**CERTIFICATION PURSUANT TO**

 

**18 U.S.C. SECTION 1350,**

 

**AS ADOPTED PURSUANT TO**

 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with theQuarterly Report on Form 10-Q of Ebix, Inc. (the “Company”) for the periodended March 31, 2006, as filed with the Securities and Exchange Commission onthe date hereof (the “Report”), I, Richard J. Baum, Chief Financial Officer ofthe Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 ofthe Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complieswith the requirements of section 13(a) or 15(d) of the Securities ExchangeAct of 1934; and

 

2. The information contained inthe Report fairly presents, in all material respects, the financial conditionand results of operations of the Company.

 

 
| By:                      | /s/ Richard  J. Baum |   |
|--------------------------|----------------------|--------|
|                     |                 |
| Name:                    | Richard J.  Baum     |   |
|                     |                 |
| Chief  Financial Officer |                 |
|                     |                 |
| May 15, 2006             |                 |
|                          |                      |        |  |

 

----
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.1 Scope. ( a ) This part sets forth the classification of general and plastic surgery devices intended for human use that are in commercial distribution.
( b ) The identification of a device in a regulation in this part is not a precise description of every device that is, or will be, subject to the regulation. A manufacturer who submits a premarket notification submission for a device under part 807 cannot show merely that the device is accurately described by the section title and identification provision of a regulation in this part, but shall state why the device is substantially equivalent to other devices, as required by § 807.87 of this chapter.
( c ) To avoid duplicative listings, a general and plastic surgery device that has two or more types of uses (e.g., used both as a diagnostic device and as a therapeutic device) is listed in one subpart only.
( d ) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.
( e ) Guidance documents referenced in this part are available on the Internet at *http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm ..*
[53 FR 23872, June 24, 1988, as amended at 67 FR 77676, Dec. 19, 2002; 78 FR 18233, Mar. 26, 2013]